相似文献
1
Remission in rheumatoid arthritis.
Curr Rheumatol Rep. 2010 Oct;12(5):355-62. doi: 10.1007/s11926-010-0121-2.
2
Progress toward the development of a new definition of remission in rheumatoid arthritis.
Bull NYU Hosp Jt Dis. 2010;68(2):140-2.
3
Patient perspective on remission in rheumatoid arthritis.
J Rheumatol. 2011 Aug;38(8):1735-8. doi: 10.3899/jrheum.110394.
4
Should modern imaging be part of remission criteria in rheumatoid arthritis?
Best Pract Res Clin Rheumatol. 2012 Dec;26(6):767-85. doi: 10.1016/j.berh.2012.10.004.
5
Methods used to assess remission and low disease activity in rheumatoid arthritis.
Autoimmun Rev. 2010 Jan;9(3):161-4. doi: 10.1016/j.autrev.2009.07.001. Epub 2009 Jul 19.
6
Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Arthritis Rheum. 2011 Oct;63(10):2865-72. doi: 10.1002/art.30494.
7
Patient-reported outcomes as assessment tools and predictors of long-term prognosis: a 7-year follow-up study of patients with rheumatoid arthritis.
Int J Rheum Dis. 2017 Sep;20(9):1193-1200. doi: 10.1111/1756-185X.12789. Epub 2015 Nov 6.
8
Monitoring rheumatoid arthritis.
Curr Opin Rheumatol. 2011 May;23(3):252-8. doi: 10.1097/BOR.0b013e328345743a.
9
What should be our treatment goal in rheumatoid arthritis today?
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-7-13.
10
Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.
Arthritis Rheum. 2009 May 15;61(5):704-10. doi: 10.1002/art.24392.
引用本文的文献
1
Does remission in rheumatoid arthritis bring kinesiophobia, quality of life, fatigue, and physical activity closer to normal?
Arch Rheumatol. 2022 Oct 19;37(4):603-612. doi: 10.46497/ArchRheumatol.2022.9552. eCollection 2022 Dec.
2
Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis.
BMC Rheumatol. 2018 Jun 26;2:16. doi: 10.1186/s41927-018-0024-9. eCollection 2018.
3
MR and ultrasound of the hands and wrists in rheumatoid arthritis. Part II. Added clinical value.
Skeletal Radiol. 2019 Jun;48(6):837-857. doi: 10.1007/s00256-019-03180-6. Epub 2019 Feb 26.
4
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone.
RMD Open. 2017 Sep 26;3(2):e000445. doi: 10.1136/rmdopen-2017-000445. eCollection 2017.
5
Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.
Am Health Drug Benefits. 2017 Feb;10(1):27-36.
6
Effect of Bizhongxiao decoction and its dismantled formulae on IL-1 and TNF levels in collagen-induced arthritis in rat synovial joints.
Theor Biol Med Model. 2012 Nov 20;9:47. doi: 10.1186/1742-4682-9-47.
7
An association study of disease activity score components and patient satisfaction with overall health for early RA patients on non-biologic DMARD therapy.
Rheumatol Int. 2012 Sep;32(9):2725-9. doi: 10.1007/s00296-011-2037-1. Epub 2011 Jul 30.
本文引用的文献
1
Remission in early rheumatoid arthritis.
J Rheumatol. 2010 Jul;37(7):1444-53. doi: 10.3899/jrheum.091131. Epub 2010 Jun 1.
2
Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up.
Scand J Rheumatol. 2010;39(1):12-8. doi: 10.3109/03009740903042394.
3
Rheumatoid arthritis: can we achieve true drug-free remission in patients with RA?
Nat Rev Rheumatol. 2010 Feb;6(2):68-70. doi: 10.1038/nrrheum.2009.253.
4
Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
J Rheumatol. 2010 Feb;37(2):285-90. doi: 10.3899/jrheum.090898. Epub 2010 Jan 15.
5
Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study.
Arthritis Res Ther. 2010;12(1):R3. doi: 10.1186/ar2901. Epub 2010 Jan 7.
6
Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.
Rheumatology (Oxford). 2010 Apr;49(4):683-90. doi: 10.1093/rheumatology/kep442. Epub 2010 Jan 4.
7
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661.
8
Methods used to assess remission and low disease activity in rheumatoid arthritis.
Autoimmun Rev. 2010 Jan;9(3):161-4. doi: 10.1016/j.autrev.2009.07.001. Epub 2009 Jul 19.
9
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse.
Rheumatology (Oxford). 2009 Sep;48(9):1092-7. doi: 10.1093/rheumatology/kep171. Epub 2009 Jun 26.
10
Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases.
J Rheumatol. 2009 Jul;36(7):1532-5. doi: 10.3899/jrheum.080434. Epub 2009 Jun 1.
Zotero 插件